Details of the Drug

General Information of Drug (ID: DM5C70M)

Drug Name

T-607

Synonyms

T-607; AC1LA5AL; 2-[(Ethyl)disulfanyl]-2-methylthioacetamide; 2-(ethyldisulfanyl)-2-methylsulfanylacetamide; 2-(ethyldisulfanyl)-2-methylsulfanyl-acetamide; 92504-EP2298748A2; 92504-EP2295416A2

Indication

Disease Entry	ICD 11	Status	REF
Solid tumour/cancer	2A00-2F9Z	Phase 2	[1]
------------------------------------------------------------------------------------

Drug Type

Small molecular drug

Structure

3D MOL

2D MOL

#Ro5 Violations (Lipinski): 0

Molecular Weight (mw)

197.3

Logarithm of the Partition Coefficient (xlogp)

1

Rotatable Bond Count (rotbonds)

5

Hydrogen Bond Donor Count (hbonddonor)

1

Hydrogen Bond Acceptor Count (hbondacc)

4

Chemical Identifiers

Formula: C5H11NOS3
IUPAC Name: 2-(ethyldisulfanyl)-2-methylsulfanylacetamide
Canonical SMILES: CCSSC(C(=O)N)SC
InChI: InChI=1S/C5H11NOS3/c1-3-9-10-5(8-2)4(6)7/h5H,3H2,1-2H3,(H2,6,7)
InChIKey: OKTRVIBXCNRKHI-UHFFFAOYSA-N

Cross-matching ID

PubChem CID: 462014
TTD ID: D07QFU

Molecular Interaction Atlas of This Drug

Drug Therapeutic Target (DTT)

DTT Name	DTT ID	UniProt ID	MOA	REF
Tubulin beta (TUBB)	TTYFKSZ	NOUNIPROTAC	Inhibitor	[2]

------------------------------------------------------------------------------------

Molecular Interaction Atlas (MIA)

MIA Detail

Jump to Detail Molecular Interaction Atlas of This Drug

References

1	ClinicalTrials.gov (NCT00054249) T900607 in Treating Patients With Gastroesophageal Junction Cancer. U.S. National Institutes of Health.
2	Nucleophilic reactions of N-ethoxycarbonyliminopyridinium ylide with alpha,beta-unsaturated carbonyl compounds. Volume 28, Issue 6, 1972, Pages 1469-1476.